Autoimmune Intervention Mastery Course Study

RECRUITING

I'm interested ...!!

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Conditions:

🦠 Multiple Sclerosis 🦠 Clinically Isolated Syndrome 🦠 Fibromyalgia 🦠 Post Acute Sequelae of COVID-19 🦠 Cancer in Remission With Persisting Fatigue

🗓️ Study Start (Actual) 1 December 2021

🗓️ Primary Completion (Estimated) 1 December 2026

✅ Study Completion (Estimated) 1 December 2026

👥 Enrollment (Estimated) 80

🔬 Study Type INTERVENTIONAL

📊 Phase NA

Locations:

📍 Iowa City, Iowa, United States

📋 Eligibility Criteria

Description

Inclusion Criteria:

* self-reported multiple sclerosis
* self-reported clinically isolated syndrome
OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis,
OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider,

Exclusion Criteria:

Ages Eligible for Study: 18 Years to 100 Years (ADULT, OLDER_ADULT)

Sexes Eligible for Study: ALL

Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted 15 September 2021
First Submitted that Met QC Criteria 15 September 2021
First Posted 27 September 2021

Study Record Updates

Last Update Submitted that Met QC Criteria 22 July 2024
Last Update Posted 24 July 2024
Last Verified July 2024